Ahmed Elsobky: Strengthening Hemophilia Care Under Egypt’s Universal Health Insurance System
Ahmed Elsobky, Chairman of the Board of Directors at Egypt Healthcare Authority, shared on LinkedIn:
”I was pleased to meet with Dr. Ayman Hassan, Chairman and General Manager of Novo Nordisk Egypt and Libya, accompanied by Dr. Ayman Afifi, Head of Government Affairs, and Dr. Farouk Zaky, Government Affairs Manager, to discuss expanding strategic cooperation during the second phase of Egypt’s Universal Health Insurance System.
Our discussions focused on strengthening collaboration in medical education and professional capacity building, in addition to advancing awareness and prevention programs targeting chronic diseases, particularly diabetes, obesity, fatty liver disease, and rare blood disorders, in line with Egypt’s vision for a more integrated, sustainable, and patient-centered healthcare system.
We firmly believe that investing in healthcare human capital is a cornerstone for improving service quality and ensuring better health outcomes.
In this regard, the Healthcare Authority Academy continues to play a pivotal role in equipping healthcare professionals with the latest evidence-based medical protocols and international best practices.
Minya Governorate represents a key model for this partnership as one of the first governorates in the second phase of the Universal Health Insurance System, given its population density and the increasing need for expanded medical training and community awareness initiatives, particularly in underserved areas.
We also reviewed the successful outcomes of our ongoing collaboration in supporting hemophilia patients across several governorates, reflecting the importance of impactful partnerships in strengthening healthcare delivery and improving patients’ quality of life within Egypt’s Universal Health Insurance framework.”
Stay updated with Hemostasis Today.
-
May 24, 2026, 04:49Hussien Hishmat: There Is More to Pulmonary Embolism than Just Anticoagulation
-
May 24, 2026, 04:25Sarah Elkourashy: Diagnostic Challenges and Management Strategies for Maternal–Fetal Outcomes in TTP
-
May 24, 2026, 04:11Ayah Ghazi Al-Qasrawi: How Should Sepsis-Induced DIC Be Managed in Patients Receiving Thienopyridines
-
May 24, 2026, 04:05Kate Hayward: Recent Stroke Recovery and Rehabilitation Highlights
-
May 24, 2026, 03:33Raghavendra Rao: Short-Term Outcomes of Combined EVLA and Foam Sclerotherapy
-
May 24, 2026, 03:33Lucia Mazzolai: Systemic Vascular Approach to Peripheral Artery Disease
-
May 24, 2026, 03:32Isaac Okello: Africa CDC Launches Continental Framework for Sickle Cell Disease
-
May 24, 2026, 03:32Karine Kocharian: Advancing Hemophilia Care Equity at the 79th World Health Assembly
-
May 24, 2026, 03:31Dima Shulkin: Emerging Biomarkers for Early Prediction of Sepsis-Induced Shock